Patient-reported outcome measure for neuromyelitis optica: pretesting of preliminary instrument and protocol for further development in accordance with international guidelines.
This study outlines the development of a patient-reported outcome measure (PROM), an instrument to obtain self-reported health status for neuromyeltis optica (NMO), a disabling neurological condition.



Development was conducted in accordance with international guidance for PROMs including systematic review of existing literature, item generation guided by qualitative interviews, health-related quality of life conceptual framework and clinical expert panel and cognitive interviews with NMO patients.



Participants were identified through a national NMO clinic in a tertiary NHS neurosciences service.



15 individuals with NMO participated in cognitive interviews requiring review and ranking of proposed PROM items and qualitative feedback on content, layout and response options.



Participants endorsed the draft instrument as reflecting their experience of the condition and as being easy to understand. Rating and ranking of item relevance and importance reduced the draft instrument from 106 to 48 items. Participant feedback on overlapping items eliminated a further 2 items and resulted in a preliminary instrument of 46 items. As a direct result of participant feedback ordering of the 10 domains was revised, a 4 option Likert scale was employed and a 4-week recall period for impact of symptoms was selected.



A 46-item instrument developed in accordance with international PROM development guidelines through literature review, developed by subject matter experts and refined through pretesting examining content validity provides a preliminary measure for assessing patient-report of health status in NMO. Further evaluation is proposed including sensitivity to clinical change, and international contributions to evaluating the measure are encouraged.
Department of Clinical Neuropsychology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
P
P
Moore
Department of Clinical Neuropsychology, The Walton Centre NHS Foundation Trust, Liverpool, UK Department of Clinical Psychology, University of Liverpool, Liverpool, UK.
C
C
Jackson
Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
K
K
Mutch
School of Psychological Sciences, University of Manchester, Manchester, UK.
A
A
Methley
Department of Clinical Neuropsychology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
C
C
Pollard
Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
S
S
Hamid
Department of Neurology, The Walton Centre NHS Foundation Trust, Liverpool, UK.
A
A
Jacob
D000328:Adult; D000368:Aged; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009471:Neuromyelitis Optica / Q000503:physiopathology*; D000071066:Patient Reported Outcome Measures; D017410:Practice Guidelines as Topic; D011788:Quality of Life; D015203:Reproducibility of Results; D057566:Self Report; D011795:Surveys and Questionnaires; D006113:United Kingdom; D055815:Young Adult
QUALITATIVE RESEARCH; REHABILITATION MEDICINE
Clin Rehabil. 2001 Jun;15(3):247-58
11386394
Mult Scler. 2012 Oct;18(10):1480-3
22354738
Neurology. 1999 Sep 22;53(5):1107-14
10496275
Eur J Neurol. 2012 Apr;19(4):655-9
21967235
Neurology. 2015 Jul 14;85(2):177-89
26092914
BMJ. 2013 Jan 28;346:f167
23358487
Value Health. 2007 Nov-Dec;10 Suppl 2:S66-75
17995476
Brain. 2007 May;130(Pt 5):1194-205
17282996
Value Health. 2011 Dec;14(8):967-77
22152165
Neurology. 2011 Aug 16;77(7):652-8
21813781
Brain. 2007 May;130(Pt 5):1224-34
17405762
Lancet Neurol. 2007 Sep;6(9):805-15
17706564
Lancet. 2004 Dec 11-17;364(9451):2106-12
15589308
Qual Life Res. 2008 Dec;17(10):1239-46
18850327
Eur J Neurol. 2011 Jun;18(6):836-41
21087360
Value Health. 2011 Dec;14(8):978-88
22152166
Med Sci Monit. 2012 Oct;18(10):CS82-4
23018359
Mult Scler. 2014 Oct;20(12):1651-3
24493471
Arch Neurol. 2012 Nov;69(11):1482-7
22926050
Disabil Rehabil. 2014;36(13):1100-7
24028351
Health Expect. 2017 Feb;20(1):47-58
26599425
Arch Neurol. 2008 Jan;65(1):84-8
18195143
Brain. 2001 May;124(Pt 5):962-73
11335698
J Neuroinflammation. 2012 Jan 19;9:14
22260418
Qual Life Res. 2012 Apr;21(3):441-51
21786186
J Neurol. 2013 Aug;260(8):2134-7
23689970
J Neurol Neurosurg Psychiatry. 2013 Aug;84(8):922-30
23142960